Today, Delaware Enhanced Global Dividend and Income Fund (the “Fund”), a
New York Stock Exchange-listed closed-end fund trading under the symbol
“DEX,” declares a monthly dividend of $0.0750 per share.
Today, Delaware Investments Dividend and Income Fund, Inc. (the “Fund”),
a New York Stock Exchange–listed closed-end fund trading under the
symbol “DDF,” declares a monthly dividend of $0.0525 per share.
Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company
focused on advanced wound care, announced today that it will hold a
conference call on August 7, 2014 to discuss the financial results for
the second quarter of 2014.
Year over year revenue growth of 13% for both periods Adjusted net income improved by more than $1.0 million and $2.7 million, respectively Announces financial guidance for 2014 Announces a regular quarterly cash dividend of $0.05 cents per share SUWANEE, Ga., Aug.
LOS ANGELES , Aug.1, 2014 /PRNewswire/ -- The DoubleLine Opportunistic Credit Fund (the "Fund"), which is traded on the New York Stock Exchange under the symbol DBL, today declared a distribution of $0.167 per share for the month of August 2014 .
Chevron Products Company, a Chevron U.S.A. Inc. division, maker of the
Delo® brand of technologically advanced engine oils, lubricants and
coolants, today announced the “Delo Pick-Up Your Truck” sweepstakes,
which offers participants a chance to win a 2014 Ford F-250 Diesel Truck
and other prizes.
By Quentin Fottrell, MarketWatch
Dating website is launching a service for bosses and employees
-Quentin Fottrell; 415-439-6400; AskNewswires@dowjones.com
Watch out, LinkedIn (LNKD) . There's a new jobs matchmaker in town.
Eleven Biotherapeutics, Inc. (Nasdaq: EBIO), a clinical-stage
biopharmaceutical company discovering and developing protein
therapeutics to treat diseases of the eye, today announced it will
report second quarter 2014 financial results on Wednesday, August 13,
The Rosen Law Firm, P.A. is investigating the Board of Directors of
Bally Technologies, Inc. (NYSE:BYI) for possible breaches of fiduciary
duties and other violations of law by failing to adequately shop Bally
Technologies to maximize shareholder value before entering into a
definitive merger agreement with Scientific Games Corporation (NASDAQ:
If you would like to join the action, please call Phillip Kim, Esq.
Alexion Pharmaceuticals (NASDAQ:ALXN) today announced that the European
Commission has granted orphan drug designation (ODD) to Soliris®
(eculizumab) for the treatment of patients with Myasthenia Gravis (MG),
a rare, debilitating neurologic disorder caused by uncontrolled
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.